← Open Payments lookup

MITCHELL GLASER: Open Payments

NPI 1598789521 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$255,531 in 479 payments from 19 companies in 2025. Trend: 2023 $148,720 · 2024 $188,121 · 2025 $255,531

Speaker / faculty: $191,675Consulting: $31,217Travel & lodging: $22,059Food & beverage: $10,580
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.148$112,246
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)76$58,997
Janssen Pharmaceuticals, Inc49$27,987
Neurocrine BioSciences, Inc.35$20,147
ABBVIE INC.47$19,405
Teva Pharmaceuticals USA, Inc.22$14,805
Alkermes, Inc.17$311
Supernus Pharmaceuticals, Inc.22$291
Lundbeck LLC12$285
Axsome Therapeutics, Inc.21$276

Products named: COBENFY, CAPLYTA, SPRAVATO, INGREZZA, VRAYLAR, UZEDY, REXULTI, Qelbree.

Industry payments across IL — which companies pay providers there.